Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review

Por Sommer, Iris E., Begemann, Marieke J. H., Temmerman, Anke, Leucht, Stefan
Publicado em 2012

Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis

Por Dauwan, Meenakshi, Begemann, Marieke J. H., Heringa, Sophie M., Sommer, Iris E.
Publicado no Schizophr Bull (2016)

Relationship between neuroticism, childhood trauma and cognitive-affective responses to auditory verbal hallucinations

Por So, Suzanne Ho-wai, Begemann, Marieke J. H., Gong, Xianmin, Sommer, Iris E.
Publicado no Sci Rep (2016)

Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update

Por Sommer, Iris E., van Westrhenen, Roos, Begemann, Marieke J. H., de Witte, Lot D., Leucht, Stefan, Kahn, René S.
Publicado em 2014

Simvastatin augmentation for recent-onset psychotic disorder: A study protocol

Por Begemann, Marieke J.H., Schutte, Maya J.L., Slot, Margot I.E., Doorduin, Janine, Bakker, P. Roberto, van Haren, Neeltje E.M., Sommer, Iris E.C.
Publicado no BBA Clin (2015)